How Much Does Semaglutide Cost? One Price at Every Dose, Less per Month on a Package
Compounded semaglutide at ACT 2 Health costs $299 a month as a weekly injection or $299 a month as a daily capsule, with the clinician's care and the medication in that one price. The injection is also sold as a 2-month package for $550 ($275 a month), and the price does not rise as the dose does.
Branded semaglutide is now also sold for cash, and as of October 14, 2026 the branded Wegovy pill starts at $149 a month, which is less than ACT 2's compounded injection. The branded cash prices section below sets out the dated figures.
This page covers the cost only. Whether semaglutide suits you is covered on the semaglutide injection page and the medical weight loss page; every ACT 2 price is on pricing.
Medically reviewed by Johnathan Chance Miller, M.D. —
Physician and holistic medicine practitioner blending rigorous clinical training with an integrative approach to longevity. Full bio
What does semaglutide cost at ACT 2?
| Treatment | Option | Price | How it is billed |
|---|---|---|---|
| Semaglutide Injection | 1 month | $299 | Monthly |
| 2 months | $550 | Once for 2 months ($275/month) | |
| Semaglutide Oral Capsules | 1 month | $299 | Monthly |
| Weight Loss Program Membership | 1 month | $75 | Monthly |
| 3 months | $150 | Once for 3 months ($50/month) |
What the price includes. The clinical care and the compounded medication, dispensed and shipped by a licensed pharmacy. There is no separate pharmacy bill and no membership fee. The assessment and eligibility review are free; you pay only if a clinician finds semaglutide appropriate and you go ahead.
What it does not include. Lab work: the program starts from a baseline, and the comprehensive panel is $199, charged once. Shipping and taxes, where they apply, are shown before you pay. Prices are the same in every state.
One further offer. $100 off your first month for new patients. It cannot be combined with the 10% welcome code, and neither applies to lab panels.
The oral semaglutide capsule is sold monthly only; only the injection has packages. The third line in the table is not semaglutide; it is explained in the insurance section below.
Does semaglutide cost more as the dose goes up?
Not at ACT 2. Semaglutide is started at a small dose and increased over the following months on a schedule your clinician sets, and where you end up differs from person to person. The price is the same at every step: the dose is not a pricing axis, so your first month and your twelfth cost the same.
Branded self-pay pricing is built differently. Novo Nordisk's NovoCare offers new patients a lower price on their first two fills of the Wegovy pen, then a higher standard price, and its prices can differ by strength. The branded cash prices section below gives the current starting figures with their date. A flat price means the figure at your first order is the one you can plan the year around.
What does a year of semaglutide cost?
These figures are for the weekly injection, catalog prices, before either new-patient offer, and they assume twelve continuous months of treatment.
| Payment pattern | What you pay up front | Works out per month | Twelve months |
|---|---|---|---|
| Monthly | $299 each month | $299 | $3,588 |
| Six 2-month packages | $550 six times | $275 | $3,300 |
Buying the year as six 2-month packages costs $3,300, against $3,588 paid month by month. Each package covers two months, so a year on packages is six payments rather than twelve.
With the baseline panel. Adding one comprehensive lab panel at the start, and assuming no further panels in the year, the package year comes to $3,499. If your clinician asks for repeat testing, each further panel adds $199.
The trade-off. A package is paid up front and commits you to two months of supply at a time, so starting monthly and moving to the package once the plan has settled is a reasonable pattern. Cancellation terms are shown at checkout. The pricing and insurance FAQ covers how billing works.
What does branded semaglutide cost for cash?
Branded semaglutide is now sold directly for cash, through TrumpRx.gov and through Novo Nordisk's NovoCare. These are the published starting prices as of October 14, 2026:
| Branded product | Starting cash price | Published by |
|---|---|---|
| Wegovy pill | Starting at $149 a month | TrumpRx.gov; NovoCare |
| Wegovy pen, a new patient's first two fills (offer runs through December 31, 2026) | $199 a month | NovoCare; TrumpRx.gov |
| Wegovy pen, after the first two fills | Starting at $349 a month | NovoCare |
| Ozempic | Starting at $199 a month | TrumpRx.gov |
| Wegovy through the Medicare GLP-1 Bridge, for eligible Medicare patients | $50 a month | NovoCare; eligibility is set by CMS |
Every figure in this table is a starting price as of October 14, 2026, set by the manufacturer, and may change. Prices can differ by strength, and NovoCare says its introductory pen pricing will be updated after December 31, 2026. Wegovy is the semaglutide brand approved for chronic weight management; Ozempic is approved for type 2 diabetes. Check TrumpRx.gov and NovoCare's Wegovy savings page (references 9 and 10) for the current figure before you decide.
How that compares with ACT 2's price. The branded Wegovy pill, starting at $149 a month, can now cost less than ACT 2's compounded semaglutide injection at $299 a month. After the two introductory fills, the branded pen starts at $349 a month, which is more than the compounded injection. The products are not interchangeable: the Wegovy pill is an FDA-approved tablet, and ACT 2's compounded semaglutide is not FDA-approved and is not equivalent to any brand.
A branded product with ACT 2's care. ACT 2 can prescribe a branded product through the Weight Loss Program Membership, at $75 a month or $150 for three months. The membership covers the clinician's care; the medication is paid to the manufacturer, separately, at the manufacturer's price. With the Wegovy pill at its starting price, the membership and the medication together come to $224 a month, before lab work. Whether a branded product suits you is a clinical decision made at your assessment.
Semaglutide cost without insurance, and with it
ACT 2 is direct-pay and does not bill insurance, Medicare or Medicare Advantage. Whether coverage could get you a branded product for less is a separate question, and sometimes the answer is yes.
Medicare. Medicare Part D excludes drugs "when used for weight loss" by statute. A Part D plan may cover a GLP-1 when it is prescribed for another medically accepted indication, such as type 2 diabetes or reducing the risk of major cardiovascular events in adults with established cardiovascular disease and overweight or obesity. CMS proposed in November 2024 to reinterpret the exclusion so that anti-obesity medications could be covered for obesity, then announced in April 2025 that it was not finalizing that change.
Separately, from July 1, 2026 to December 31, 2027, CMS runs a short-term demonstration, the Medicare GLP-1 Bridge. It gives eligible Part D enrollees certain branded GLP-1 drugs for weight reduction at a fixed monthly copayment, subject to prior authorization and body-mass-index and health-condition criteria, outside the normal Part D benefit. The drugs named are Wegovy, Zepbound KwikPen and Foundayo; compounded semaglutide is not on the list. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible, though Medicare notes their Part D plan might cover a GLP-1. Novo Nordisk states that eligible Medicare patients prescribed Wegovy for weight loss pay $50 a month under the Bridge, as of October 14, 2026. If you qualify, that route will usually cost you less out of pocket than any self-pay option, ours included.
Commercial insurance. Coverage varies by plan and by year. A GLP-1 on your plan's formulary is not automatically covered for you: prior authorization and the plan's own criteria sit in between.
The branded route through your own coverage. If your commercial plan covers a branded GLP-1 for you, fill it that way. The Weight Loss Program Membership is $75 a month for the clinical oversight, monitoring and plan review around a branded medication; your own pharmacy bills you for the drug separately.
HSA and FSA. Eligibility is set by your plan administrator and IRS rules, and ACT 2 cannot declare a purchase eligible. FSA and HSA at year-end covers the deadlines.
Why compounded semaglutide is priced differently from Wegovy
The semaglutide prescribed through ACT 2 is compounded by a licensed pharmacy. It is not FDA-approved, and it is not the same as, equivalent to or interchangeable with Wegovy, Ozempic or any other branded product. The FDA states that it does not review compounded drugs for safety, effectiveness or quality before they are marketed. Branded semaglutide is FDA-approved and priced by its manufacturer, so the two prices describe two different kinds of product. The compounded semaglutide versus Wegovy page sets out the differences.
What changes the number
- Payment pattern. Monthly or the 2-month package, as in the year table.
- Lab work. $199 per comprehensive panel.
- New-patient offers. The first-month offer described above, or 10% off the first order through the welcome offer. The two cannot be combined, and neither applies to lab panels or to branded medication billed by your own pharmacy.
- Switching medication. Compounded tirzepatide is priced differently; the tirzepatide cost page sets out that arithmetic.
The dose is not on this list, because it does not change the price.
Frequently asked questions
Compounded semaglutide costs $299 a month at ACT 2 as a weekly injection or $299 as a daily capsule, with the clinician's care and the medication included. The injection also comes as a 2-month package at $275 a month. Lab work is priced separately, and shipping and taxes where they apply are shown before you pay.
No, the price of semaglutide at ACT 2 is the same at every dose. Your clinician increases the dose over the first months on a schedule suited to you, and the monthly or package price does not change as that happens. Branded self-pay pricing works differently: NovoCare's Wegovy pen price rises after a new patient's first two fills. At ACT 2 the figure at your first order is the one you can budget the year around.
The 2-month semaglutide injection package costs $550, paid up front, which works out to $275 a month. It costs more at checkout and less per month than paying monthly. The oral capsule is sold monthly only, and cancellation terms for each option are shown at checkout.
A year of the semaglutide injection costs $3,588 paid monthly, or $3,300 bought as six 2-month packages, assuming twelve continuous months at catalog prices. Adding one comprehensive lab panel at the start brings the package year to $3,499. Repeat panels, if your clinician asks for them, add $199 each.
Medicare Part D excludes drugs used for weight loss by statute, though a plan may cover a GLP-1 prescribed for another medically accepted indication such as type 2 diabetes. From July 2026 to December 2027, the Medicare GLP-1 Bridge gives eligible enrollees certain branded GLP-1s for weight reduction, with prior authorization; Novo Nordisk states that eligible patients pay $50 a month for Wegovy, as of October 14, 2026. Compounded semaglutide is not included. ACT 2 does not bill Medicare.
As of October 14, 2026, the Wegovy pill starts at $149 a month for cash, and the Wegovy pen is $199 a month for a new patient's first two fills through December 31, 2026, then starts at $349 a month. Ozempic starts at $199 a month on TrumpRx.gov. These prices are set by the manufacturer and may change, so check TrumpRx.gov or NovoCare before you decide.
No, and the products are not the same either. ACT 2 prescribes compounded semaglutide, which is not FDA-approved and is not equivalent to Wegovy or Ozempic. As of October 14, 2026, the branded Wegovy pill starts at $149 a month for cash, which is less than ACT 2's compounded injection at $299. ACT 2 can prescribe a branded product through the Weight Loss Program Membership at $75 a month, with the medication paid to the manufacturer separately.
Where this fits in your plan
Settle the coverage question first. If Medicare or your plan covers a branded GLP-1 for you, that is usually the less expensive route for the medication. If nothing is covered, compare the ACT 2 table and the dated branded cash prices above, plus lab work. Whether semaglutide is right for you at all is a clinical decision, made at your assessment.
We measure first. Then we act.
References
- Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge coverage and eligibility). Centers for Medicare & Medicaid Services. https://www.medicare.gov/coverage/weight-loss-drugs
- Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge. CMS, 2026. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- Centers for Medicare & Medicaid Services. Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program… (CMS-4208-P), fact sheet. CMS, November 2024. https://www.cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription
- Centers for Medicare & Medicaid Services. Contract Year 2026 Policy and Technical Changes… (CMS-4208-F), final rule fact sheet. CMS, April 2025. https://www.cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription-final
- HealthCare.gov. Prior authorization (glossary). U.S. Centers for Medicare & Medicaid Services. https://www.healthcare.gov/glossary/prior-authorization/
- HealthCare.gov. Formulary (glossary). U.S. Centers for Medicare & Medicaid Services. https://www.healthcare.gov/glossary/formulary/
- U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss. FDA. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Novo Nordisk. NovoCare Pharmacy: self-pay and insurance options for Wegovy and Ozempic (manufacturer's official page). https://www.novocare.com/pharmacy.html
- TrumpRx.gov. Wegovy, Ozempic and Zepbound cash prices ("Lowest Presidential Deal"). U.S. Government, checked October 14, 2026. https://trumprx.gov/
- Novo Nordisk. Savings Offer Program for Wegovy (semaglutide): self-pay prices for the Wegovy pill and pen, and the Medicare GLP-1 Bridge (NovoCare). Checked October 14, 2026. https://www.novocare.com/patient/medicines/wegovy/savings-offer.html
- Back toPricing
- Semaglutide injectionA GLP-1 receptor agonist that works with your body's appetite and blood-sugar signaling to support weight management.Read
- Oral semaglutideAn oral semaglutide option for those who would rather avoid injections.Read
- Compounded semaglutide vs WegovyCompounded semaglutide is not Wegovy. How compounding works, what the FDA changed in 2026, and the questions to ask before filling a prescription.Read
- Tirzepatide costCompounded tirzepatide at ACT 2 is $399 a month with care included, or $375/mo on a 2-month package. What a full year costs.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.
ACT 2 prices shown are current catalog prices and are confirmed at your eligibility review. Branded prices are starting prices published by TrumpRx.gov and the manufacturer as of October 14, 2026; they are set by the manufacturer, are not ACT 2 prices, and may change; Medicare and insurance rules described here were checked against CMS and Medicare.gov in September 2026 and can change.